Osteogenesis imperfecta, diffuse idiopathic skeletal hyperostosis, and hypophosphatasia: one year in review 2025

0Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

There are several metabolic bone diseases that rheumatologists should be aware of in clinical practice. In this paper, we reviewed the literature published in 2024 on osteogenesis imperfecta, diffuse idiopathic skeletal hyperostosis, and hypophosphatasia.

Cite

CITATION STYLE

APA

De Mattia, G., Pisapia, L., Sgorbini, C., & Mazzantini, M. (2025, July 1). Osteogenesis imperfecta, diffuse idiopathic skeletal hyperostosis, and hypophosphatasia: one year in review 2025. Clinical and Experimental Rheumatology. Clinical and Experimental Rheumatology S.A.S. https://doi.org/10.55563/clinexprheumatol/3ol69g

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free